de Boer RA - Search Results

1

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies.

Stege NM, de Boer RA, van den Berg MP, Silljé HHW. Stege NM, et al. Among authors: de boer ra. Int J Mol Sci. 2021 Mar 14;22(6):2955. doi: 10.3390/ijms22062955. Int J Mol Sci. 2021. PMID: 33799487 Free PMC article. Review.

2

Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.

Tjeerdsma G, de Boer RA, Boomsma F, van den Berg MP, Pinto YM, van Veldhuisen DJ. Tjeerdsma G, et al. Among authors: de boer ra. Int J Cardiol. 2002 Dec;86(2-3):143-9; discussion 149-52. doi: 10.1016/s0167-5273(02)00409-6. Int J Cardiol. 2002. PMID: 12419550

3

A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.

Asselbergs FW, Moore JH, van den Berg MP, Rimm EB, de Boer RA, Dullaart RP, Navis G, van Gilst WH. Asselbergs FW, et al. Among authors: de boer ra. BMC Med Genet. 2006 Apr 19;7:39. doi: 10.1186/1471-2350-7-39. BMC Med Genet. 2006. PMID: 16623947 Free PMC article.

4

Genetics in heart failure: where are we headed?

de Boer RA, van den Berg MP, van Veldhuisen DJ. de Boer RA, et al. Congest Heart Fail. 2006 Nov-Dec;12(6):329-32. doi: 10.1111/j.1527-5299.2006.05724.x. Congest Heart Fail. 2006. PMID: 17170587 Free article. Review.

5

Brugada syndrome or Brugada electrocardiogram?

van den Berg MP, de Boer RA, van Tintelen JP. van den Berg MP, et al. Among authors: de boer ra. J Am Coll Cardiol. 2009 Apr 28;53(17):1569; author reply 1569-70. doi: 10.1016/j.jacc.2008.12.057. J Am Coll Cardiol. 2009. PMID: 19389571 Free article. No abstract available.

6

Pharmacogenetics in heart failure: promises and challenges.

de Boer RA, van der Harst P, van Veldhuisen DJ, van den Berg MP. de Boer RA, et al. Expert Opin Pharmacother. 2009 Aug;10(11):1713-25. doi: 10.1517/14656560903025171. Expert Opin Pharmacother. 2009. PMID: 19558337 Review.

7

Myostatin: an overlooked player in heart failure?

Silljé HH, de Boer RA. Silljé HH, et al. Among authors: de boer ra. Eur J Heart Fail. 2010 May;12(5):420-2. doi: 10.1093/eurjhf/hfq044. Epub 2010 Mar 27. Eur J Heart Fail. 2010. PMID: 20348549 Free article. No abstract available.

8

Meeting highlights from the 2010 European society of cardiology heart failure association winter meeting: translational heart failure research.

de Boer RA, Shah AM, Silljé HH. de Boer RA, et al. Eur J Heart Fail. 2010 May;12(5):417-9. doi: 10.1093/eurjhf/hfq064. Eur J Heart Fail. 2010. PMID: 20410330 Free article. No abstract available.

9

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.

Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Silljé HH. Oeseburg H, et al. Among authors: de boer ra. Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1407-14. doi: 10.1161/ATVBAHA.110.206425. Epub 2010 May 6. Arterioscler Thromb Vasc Biol. 2010. PMID: 20448207

10

Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.

Kuipers I, Li J, Vreeswijk-Baudoin I, Koster J, van der Harst P, Silljé HH, Kuipers F, van Veldhuisen DJ, van Gilst WH, de Boer RA. Kuipers I, et al. Among authors: de boer ra. Eur J Heart Fail. 2010 Oct;12(10):1042-50. doi: 10.1093/eurjhf/hfq109. Epub 2010 Jun 29. Eur J Heart Fail. 2010. PMID: 20587624 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page